Literature DB >> 20972807

CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.

Rudy J Castellani1, Summer L Nugent, Alan L Morrison, Xiongwei Zhu, Hyoung-Gon Lee, Peggy L R Harris, Vladan Bajić, Hari S Sharma, Shu G Chen, Peter Oettgen, George Perry, Mark A Smith.   

Abstract

CD3ζ is a subunit of the CD3 molecule that, until recently, appeared restricted to T cells and natural killer cells. However, experimental studies have demonstrated a role of CD3ζ in dendritic outgrowth in the visual system as well as in synaptic plasticity. Given the increasing evidence for uncharacteristic recapitulation of neurodevelopmental processes in neurodegenerative diseases, in this study, we evaluated brains from subjects with Parkinson's disease and Lewy body dementia for evidence of aberrant CD3 expression. Our data shows marked CD3ζ in association with the α-synuclein containing pathological lesions, i.e., Lewy bodies and Lewy neurites, in the brains of subjects with Parkinson's disease and Lewy body dementia. This finding raises the novel concept of CD3 dysregulation in these disorders as a pathogenic factor and also furthers the increasing evidence that the recall of aberrant neurodevelopmental processes underlies the pathogenesis of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972807      PMCID: PMC3090073          DOI: 10.1007/s00702-010-0485-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

Review 1.  On guard--activating NK cell receptors.

Authors:  L L Lanier
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

2.  Functional requirement for class I MHC in CNS development and plasticity.

Authors:  G S Huh; L M Boulanger; H Du; P A Riquelme; T M Brotz; C J Shatz
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

3.  Transmitter-evoked local calcium release stabilizes developing dendrites.

Authors:  Christian Lohmann; Karen L Myhr; Rachel O L Wong
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 4.  Immune signalling in neural development, synaptic plasticity and disease.

Authors:  Lisa M Boulanger; Carla J Shatz
Journal:  Nat Rev Neurosci       Date:  2004-07       Impact factor: 34.870

5.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology.

Authors:  M A Smith; S Taneda; P L Richey; S Miyata; S D Yan; D Stern; L M Sayre; V M Monnier; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

6.  p38 mitogen-activated protein kinase-independent induction of gadd45 expression in nerve growth factor-induced apoptosis in medulloblastomas.

Authors:  T T Chou; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  2001-09-05       Impact factor: 5.157

7.  Semaphorin 3A is a chemoattractant for cortical apical dendrites.

Authors:  F Polleux; T Morrow; A Ghosh
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 8.  T-cell receptor signal transmission: who gives an ITAM?

Authors:  Lisa A Pitcher; Nicolai S C van Oers
Journal:  Trends Immunol       Date:  2003-10       Impact factor: 16.687

9.  Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII.

Authors:  Charles C Fink; Karl-Ulrich Bayer; Jason W Myers; James E Ferrell; Howard Schulman; Tobias Meyer
Journal:  Neuron       Date:  2003-07-17       Impact factor: 17.173

10.  T cell development in mice lacking the CD3-zeta/eta gene.

Authors:  M Malissen; A Gillet; B Rocha; J Trucy; E Vivier; C Boyer; F Köntgen; N Brun; G Mazza; E Spanopoulou
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  5 in total

1.  Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease.

Authors:  Asya Ozkizilcik; Aruna Sharma; Dafin F Muresanu; José V Lafuente; Z Ryan Tian; Ranjana Patnaik; Herbert Mössler; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 2.  Immune Signaling in Neurodegeneration.

Authors:  Timothy R Hammond; Samuel E Marsh; Beth Stevens
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

3.  Aspects of innate immunity and Parkinson's disease.

Authors:  Yue Huang; Glenda M Halliday
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

4.  A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.

Authors:  Peter Holmans; Valentina Moskvina; Lesley Jones; Manu Sharma; Alexey Vedernikov; Finja Buchel; Mohamad Saad; Mohamad Sadd; Jose M Bras; Francesco Bettella; Nayia Nicolaou; Javier Simón-Sánchez; Florian Mittag; J Raphael Gibbs; Claudia Schulte; Alexandra Durr; Rita Guerreiro; Dena Hernandez; Alexis Brice; Hreinn Stefánsson; Kari Majamaa; Thomas Gasser; Peter Heutink; Nicholas W Wood; Maria Martinez; Andrew B Singleton; Michael A Nalls; John Hardy; Huw R Morris; Nigel M Williams
Journal:  Hum Mol Genet       Date:  2012-12-07       Impact factor: 6.150

5.  Neuroinflammation in dementia with Lewy bodies: a human post-mortem study.

Authors:  Jay Amin; Clive Holmes; Robert B Dorey; Emanuele Tommasino; Yuri R Casal; Daisy M Williams; Charles Dupuy; James A R Nicoll; Delphine Boche
Journal:  Transl Psychiatry       Date:  2020-08-03       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.